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Rochester, New YorkABSTRACT We investigated the association of signaling proteins with epidermal growth factor (EGF) receptors (EGFR) using
biotinylated EGF bound to streptavidin that is covalently coupled in an ordered array of micron-sized features on silicon surfaces.
Using NIH-3T3 cells stably expressing EGFR, we observe concentration of fluorescently labeled receptors and stimulated tyro-
sine phosphorylation that are spatially confined to the regions of immobilized EGF and quantified by cross-correlation analysis.
We observe recruitment of phosphorylated paxillin to activated EGFR at these patterned features, as well as b1-containing in-
tegrins that preferentially localize to more peripheral EGF features, as quantified by radial fluorescence analysis. In addition, we
detect recruitment of EGFP-Ras, MEK, and phosphorylated Erk to patterned EGF in a process that depends on F-actin and
phosphoinositides. These studies reveal and quantify the coformation of multiprotein EGFR signaling complexes at the plasma
membrane in response to micropatterned growth factors.INTRODUCTIONEpidermal growth factor receptor (EGFR) belongs to the
family of receptor tyrosine kinases (RTK) that are key con-
tributors to cancer progression in multiple cell types (1).
EGFR signaling is known to be an important regulator of
cellular responses, including proliferation, migration, and
apoptosis (2–4). Numerous studies have shown that overex-
pression and mutations in EGFRs can make them potent on-
coproteins (5). EGF binding and dimerization of EGFR
activates the cytoplasmic kinase domain with consequent
transphosphorylation of tyrosine residues in this region of
EGFR (2). These phosphorylated tyrosine residues act as
docking sites for signaling adaptors, including Grb2, Shc,
and enzymes such as phospholipase Cg (PLCg), thus link-
ing EGFR to its downstream signaling partners. EGFR acti-
vation results in initiation of several signaling cascades,
including those activating extracellular signal-regulated
kinases (Erk) (2,6) via Ras, as well as Akt signaling through
phosphatidylinositol 3-kinase (PI3K) activation. EGF bind-
ing also causes internalization of EGFR, which further reg-
ulates receptor signaling capacity (7).
Although the protein participants and signaling sequelae
are well established, less is understood about the structural
organization of signaling partner interactions with activated
EGFR. Previous results using beads conjugated with EGF
have shown that localized stimulation of EGFR can cause
lateral propagation of EGFR activation at the plasma mem-
brane at a length scale of several microns (8). Effects ofSubmitted July 7, 2014, and accepted for publication September 30, 2014.
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focus of some recent studies. Evidence that EGFRs can
continue signaling from endosomes has been described,
and clathrin-mediated endocytosis of EGFR has been sug-
gested to play a role in the activation of Erk (9,10). In
contrast, other studies revealed that a reduction in EGF-
stimulated endocytosis of EGFR leads to more sustained
activation of Akt, suggesting that EGFR signaling occurs
primarily at the plasma membrane (11). Recent studies in
prostate cancer cells provided evidence that an adaptor
protein, paxillin, participates in Erk activation and its subse-
quent nuclear translocation downstream of EGFR signaling
(12,13). Physical association of activated EGFR with paxil-
lin and other downstream signaling partners, including
MEK and Erk, have not been described for intact cells.
Although F-actin association with activated EGFR was pre-
viously described (14,15), the role of F-actin in the recruit-
ment of signaling partners to activated EGFR at the plasma
membrane has not been defined.
We previously demonstrated that micropatterned ligand
surfaces are useful tools to study the spatiotemporal aspects
of FcεRI signaling (16,17). We showed that FcεRI bound to
anti-DNP-IgE on the surface of mast cells is recruited and
activated by spatially defined patterns of DNP-presenting
features. This activation leads to the corecruitment of Lyn,
a Src family tyrosine kinase that initiates the phosphoryla-
tion of FcεRI. In addition, we found that micron-scale
recruitment of Lyn to FcεRI complexes requires polymeri-
zation of actin, although this is not necessary for sufficient
recruitment of Lyn to initiate FcεRI phosphorylation
(16,17). Previous studies have shown that EGF attached tohttp://dx.doi.org/10.1016/j.bpj.2014.09.048
2640 Singhai et al.surfaces can stimulate EGFR, as detected by tyrosine phos-
phorylation (18–20).
Here, we use NIH-3T3 cells stably expressing EGFR and
micron-sized features of surface-attached EGF to locally
activate EGFR in well-defined geometrical arrays. Under
these conditions, we find that Ras, as well as MAP kinase
proteins MEK and phospho-Erk (pErk), are recruited to
the pattern-localized EGFR signaling complexes at the
plasma membrane in an actin polymerization-dependent
manner. Furthermore, we find that paxillin is recruited to
these activated EGFR signaling complexes as tyrosine-
and serine-phosphorylated species. We find that F-actin co-
localizes with these EGFR signaling complexes in a PI(4,5)
P2-dependent manner that also correlates with the preferen-
tial localization of b1 integrin to more peripheral sites of
cell engagement with EGF. Our results provide strong evi-
dence that EGFR signaling complexes are established by
surface-attached EGF, and that these complexes are stabi-
lized by coupling to the actin cytoskeleton.MATERIALS AND METHODS
All cell culture reagents, EGF and N-terminal-labeled EGF-biotin,
Lipofectamine 2000, and precast gels for blotting were from Invitrogen
(Carlsbad, CA), as were Alexa488-labeled goat antimouse IgG1,
Alexa488-labeled goat antirabbit (HþL), Alexa488-labeled donkey antirat
IgG (HþL), Alexa488- and Alexa647-phalloidin, Alexa647-labeled goat
antimouse IgG (HþL), Alexa633-labeled goat antimouse IgG2b (g2b),
and Alexa568-labeled streptavidin. FuGene HD was from Roche Applied
Sciences (Indianapolis, IN). Quercetin and phenylarsine oxide (PAO)
were purchased from Sigma-Aldrich (St. Louis, MO). PP2 was purchased
from Enzo LifeSciences (Farmingdale, NY). Cytochalasin D, Iressa, and ra-
pamycin were purchased from Calbiochem (EMD Chemicals, San Diego,
CA). Rabbit anti-pErk and anti-phosphotyrosine 1068-EGFR antibodies
were purchased from Cell Signaling Technology (Danvers, MA). Rabbit
anti-MEK antibody was from Dr. R. Cerione (Cornell University). Mouse
monoclonal anti-phosphotyrosine, clone 4G10, FITC-labeled rat anti-b1 in-
tegrin, and rabbit anti-C-terminal EGFR were obtained from Millipore
(Temecula, CA). Anti-phosphotyrosine paxillin was purchased from Santa
Cruz Biotechnology (Santa Cruz, CA). Dynamin 2-EGFP cDNA was ob-
tained from Dr. M. McNiven (The Mayo Clinic). Rabbit anti-ezrin and
anti-moesin antibodies were from Dr. A. Bretscher (Cornell University).
Avian paxillin-EGFP cDNA was from Dr. A. Horwitz (University of Vir-
ginia). EGFR-EGFP cDNA was from Dr. J. Koland (University of Iowa)
(21). Preparation of Lyn-mRFP cDNA was described previously (22).
The cDNA construct of PLCg1-EGFP (23) was from Dr. G. Carpenter
(Vanderbilt University). EGFP-H-Ras was from Dr. A. Kenworthy (Vander-
bilt University). Plasma membrane-targeted CFP-FRB domain (PM-CFP-
FRB) and mRFP-tagged FKBP12- phosphoinositide 5-phosphatase
(mRFP-FKBP12-5ptase) cDNA (24) were obtained from Dr. M. Korze-
niowski (Cornell University). The mRFP sequence was excised using poly-
merase chain reaction.Cell culture and transfection
NIH-3T3 cells stably overexpressing wild-type EGFR, hereafter referred to
as NIH-3T3 (EGFR) cells, were cultured as monolayers in Dulbecco’s
modified Eagle’s medium containing 10% (v/v) calf serum (3) as described
elsewhere (25). Chemical transfection of cells was carried out using a com-
plex of 2 mg cDNAwith 8 mL Fugene HD (Promega, Madison, WI) in 100Biophysical Journal 107(11) 2639–2651mL Opti-MEM (Life Technologies, Grand Island, NY) that was added to
plated cells in 1 mL Opti-MEM per MatTek (Ashland, MA) well. After
3–5 h, cells were returned to medium for overnight culture. For use in ex-
periments, NIH-3T3 (EGFR) cells were serum starved for 12–14 h before
harvesting.Microfabrication of patterned EGF surfaces
Surfaces with 1.5 to 4 mm features were patterned with a parylene layer as
described previously (26,27). An 8  8 mm parylene-patterned silicon sub-
strate was prepared for functionalization by plasma cleaning for 5 min at
room temperature under vacuum in a glass dish. The surface was rinsed
with acetone and dried under nitrogen, followed by treatment with 3-mer-
captopropyltrimethyoxysilane for 30 min at room temperature. The sub-
strate was then washed with absolute ethanol (3) and incubated in
2 mM N-(g-maleimidobutyryloxy)succinimide in absolute ethanol for 1 h
at room temperature (28). The samples were rinsed with phosphate buffered
saline (PBS, pH 7.4) and placed on parafilm, followed by incubation with
50 mg/mL Alexa568-streptavidin for 1 h at room temperature. After
washing with PBS, samples were incubated with 500 ng/mL EGF-biotin
for 30 min at room temperature and rinsed thoroughly with PBS. The par-
ylene was then mechanically peeled away to yield patterned EGF on the sil-
icon substrate. For negative controls, incubation with EGF-biotin was
omitted. Nonspecific binding to the micropatterned substrate was mini-
mized by incubation with 1 mg/mL bovine serum albumin (BSA) in PBS
for 5 min before plating cells for experiments.Fluorescence microscopy
For experiments involving patterned EGF surfaces, ~100 mL of cells sus-
pended at a concentration of 0.5  106 cells per mL in buffered salt so-
lution (BSS: 135 mM NaCl, 5.0 mM KCl, 1.8 mM CaCl2, 1.0 mM
MgCl2, 5.6 mM glucose, and 20 mM Hepes pH 7.4) with 1 mg/ml
BSA were added to a patterned substrate (~8  8 mm) in the center of
a 35-mm petri dish with a coverglass insert (0.16–0.19 mm; MatTek).
After 40 min of incubation at 37C (or as otherwise indicated), cells
were fixed with 4% paraformaldehyde in PBS for 20 min at room temper-
ature followed by quenching with 10 mg/ml BSA in PBS with 0.01%
NaN3 (PBS/BSA). For immunofluorescence after fixation, cells were
labeled with a primary antibody at room temperature for 1 h in presence
of 0.1% Triton-X100 in PBS/BSA. After washing with PBS/BSA, a fluo-
rophore-labeled secondary antibody was incubated with samples at room
temperature for 1 h in PBS/BSA. For labeling of F-actin, fixed cells were
incubated with 5 mg/mL Alexa488-phalloidin or Alexa647-phalloidin in
PBS-BSA with 0.1% Triton-X for 30 min at room temperature before
rinsing with PBS.
Labeled silicon chips with adherent fixed cells were inverted in a cover-
slip dish for imaging on a Zeiss LSM 710 inverted confocal microscope
and a 63 Oil Plan-Apochromat objective. A DF 488/561/647 filter set
was used to perform sequential 1/2/3 color imaging of the samples. The
width of the focal plane was adjusted for optimal image quality. For ex-
periments in which the phosphoinositide-5-phosphatase was recruited to
the plasma membrane, rapamycin (100 nM) was added to NIH-3T3
(EGFR) cells coexpressing PM-CFP-FRB and FKBP12-5ptase just before
allowing them to settle on EGF patterns and were fixed as described
previously.Quantification of colocalization
1) Pearson’s cross-correlation coefficients were determined on a cell-by-
cell basis using a MATLAB (The MathWorks, Natick, MA) code as
described elsewhere (17). The equation used to calculate Pearson’s
cross-correlation coefficient (r) is
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where, xi and yi are the pixel intensity values for the two color channels
being compared, and x and y are the average values of xi and yi in the
respective channels. A mask is drawn around the edge of the cell of inter-
est using a MATLAB script, and r values are calculated for each individ-
ual cell. Statistical analyses were carried out by calculating the p values
using Student’s t-test, and a value of p % 0.05 was considered to be sta-
tistically significant.
2) Radial analysis of fluorescence intensity, averaged over selected
patterned features, was used in cases where the labeled cellular compo-
nent was not uniformly distributed across the underlying features. In
these studies, for example, patterned features at the cell edge were
compared to features in the cell middle to evaluate differential distribu-
tions of labeled components. As depicted in Fig. S1 in the Supporting
Material, a MATLAB code is used to identify patterned features in a
selected region of interest (e.g., cell edge), based on the localization
of fluorescent streptavidin. The fluorescence intensities of the labeled
cellular response component (e.g., pTyr or b1 integrin) associated
with features located in this same region are then grouped together as
an average, representing the cellular response distribution in that region.
Pixel intensity values radiating from the feature center are averaged to
yield a radial plot, which delineates the feature edge and thereby spec-
ifies locations On versus Off the patterned feature. The ratio of averaged
fluorescence intensity values, On Pattern:Off Pattern, is taken as a quan-
titative measure of the relative cellular response distribution in terms of a
particular labeled component.
This versatile analysis scheme offers a more detailed assessment of fluo-
rescence for distinct regions of a cell. For relevant experiments in our
studies, an average value for the cellular response distribution was deter-
mined separately for those patterned features contacting only the interior
of the cell (Cell Middle), or for just those features located at the cell periph-
ery (Cell Edge), or for both of these inner and outer regions combined
(Entire Cell).
For both of these methods, analysis depends on confocal imaging of
labeled cell components at the ventral plasma membrane, and is largely in-
dependent of cell morphology in the vicinity of the patterned features. Oc-
casionally some cells (<10%) appear markedly distorted because dynamic
membrane extensions are anchored by membrane EGFR binding to the
patterned EGF. Although in extreme cases this could enhance apparent
values for colocalization of labeled components with patterned features,
we expect this effect to be small for our comparisons of values averaged
over many cells.Immunoblot analysis
Cells were lysed in 25 mM Tris, 100 mM NaCl, 1 mM EDTA, 1% (v/v)
Triton X-100, 1 mM dithiothreitol, 1 mM sodium orthovanadate, 1 mM
b-glycerol phosphate, 1 mg/mL of leupeptin, and 1 mg/mL aprotinin
(lysis buffer), and whole-cell lysates (WCL) were recovered in the su-
pernatant following microfuge centrifugation. Protein concentrations of
the WCL were determined using the Bio-Rad DC protein assay. WCL
(40 mg) were resolved by sodium dodecyl sulfate polyacrylamide gel
electrophoresis, and proteins were transferred to poly(vinylidene fluo-
ride) membranes. Membranes were blocked by 10% (w/v) BSA in
20 mM Tris, 135 mM NaCl, and 0.02% Tween 20 (TBST) and incu-
bated with the indicated primary antibodies diluted in TBST. The pri-
mary antibodies were detected with horseradish peroxidase-conjugated
antimouse IgG (GE Healthcare, Buckinghamshire, UK) diluted in
TBST followed by exposure to enhanced chemiluminescence (ECL) re-
agent (Invitrogen).RESULTS
Cellular EGFR is activated on micropatterned
EGF surfaces
Micropatterned surfaces, with A568-streptavidin covalently
attached to silicon substrates, were prepared as described in
Materials and Methods. Fig. 1 A schematically depicts the
preparation of micropatterned surfaces with the parylene
lift-off method and association of cells with these surfaces.
NIH-3T3 cells endogenously express a small amount of
EGFR that is difficult to detect by immunocytochemistry
(A. Singhai, unpublished results). To visualize EGFR
more clearly, we used NIH-3T3 cells stably overexpressing
EGFR (NIH-3T3 (EGFR) cells), which is localized primar-
ily at the plasma membrane in these cells (25). As shown in
Fig. 1 B, green channel, we find that EGFR, labeled with an
anti-EGFR, is maximally recruited to the EGF patches
within 40 min at 37C. Similar results are obtained with
RBL-2H3 cells transiently transfected with EGFP-tagged
EGFR (A. Singhai, unpublished results). Under these condi-
tions, we detect robust tyrosine phosphorylation colocalized
at patterned features with clustered EGFR, most likely due
to EGFR kinase activity (Fig. 1 B, blue channel and over-
lay). This receptor recruitment and tyrosine phosphorylation
can be detected as early as 10 min after plating in >90% of
the imaged cells, with increasing intensity at times up to
40 min after plating at 37C (A. Singhai, unpublished re-
sults). This time course for binding and activation appears
slower than observed with an optimal dose of soluble EGF
and Western blot detection (e.g., see Fig. 6). This apparent
kinetic difference may be due in part to more limited acces-
sibility or density of the pattern-associated EGF, but it is pri-
marily limited by the time of cell settling on the patterns, as
previously determined for FcεRI engagement of liganded
patterns by RBL mast cells (16). Incubation of the patterns
with a 10-fold higher dose of EGF-biotin did not enhance
these kinetics. Clustering of EGFR and enhanced tyrosine
phosphorylation depend on the presence of EGF at the
patterned sites (Fig. 1 B).
Recruitment of labeled components to the micron-sized
features can be quantified using Pearson’s cross-correlation
analysis, which evaluates the spatial coincidence of two
distinct labels (17). Consistent with our qualitative observa-
tions in confocal images, we find that Pearson’s cross-corre-
lation coefficient, r, is ~0.7 for EGFR localized to EGF
features, and ~0.05 in the absence of EGF-biotin (Fig. 1
C). Similarly, r for tyrosine phosphorylation at the patterns
is ~0.8 in presence of EGF and ~0.06 in its absence.
We also detect phosphorylation of EGFR by labeling with
an antibody specific for EGFR-phospho-tyrosine 1068
(Fig. S2 A). Iressa (gefitinib) is a potent inhibitor of the tyro-
sine kinase activity of EGFR (29). When NIH-3T3 (EGFR)
cells are serum-starved overnight and plated in the presence
of 10 mM Iressa for 40 min at 37C on patterned EGFBiophysical Journal 107(11) 2639–2651
FIGURE 1 EGFR and phosphotyrosine labeling
concentrate with patterned EGF. (A) A schematic
shows the fabrication of EGF patterned surfaces
and subsequent incubation of cells on the patterned
substrate. (B) NIH-3T3 cells stably overexpressing
EGFR were plated onto micropatterned, covalently
immobilized EGF (A568-streptavidin, red chan-
nel), fixed, and immunolabeled with anti-EGFR
primary antibody and A488-tagged secondary anti-
body (green channel), together with an anti-
phosphotyrosine primary antibody (4G10) and
A647-tagged secondary antibody (blue channel).
The bottom panel shows NIH-3T3 (EGFR) cells
plated on micropatterned surfaces of covalently
immobilized A568-streptavidin without EGF-
biotin. (C) Quantification of colocalization from
Pearson’s cross-correlation coefficient analysis
compares the green channel (EGFR) with the red
channel (streptavidin), and the blue channel (anti-
phosphotyrosine) with the red channel, as
described in Materials and Methods; N > 40 cells
for three independent experiments. Error bars
represent mean 5 SE; **** indicates p %
0.0001. Scale bar 20 mm. To see this figure in color,
go online.
TABLE 1 Summary of observationsa
2642 Singhai et al.substrates, there is little or no tyrosine phosphorylation at
EGF features, even though EGFR is recruited to the EGF
features under these conditions (Fig. S2, A and B). These ob-
servations are compiled together with others described in
Table 1.Protein Control þPP2 þIressa
þPAO or
quercetin þCyto D
EGFR Yes Yes Yes Yes Yes
p-EGFR Yes Yes None Yes Yes
p-Tyr Yes Yes Very weak Yes Yes
Paxillin-EGFP Yes Yes None None None
p-Tyr-Paxillin Yes None – – –
p-Ser-Paxillin Yes Yes - – –
F-actin Yes Yes None None None
Ezrin None – – – –
Moesin None – – – –
EGFP-H-Ras Yes Yes – – None
MEK Yes – – – None
pErk Yes – – None None
PLCg1-EGFP Yes – – – –
b1 integrin Yes – – – –
Dynamin 2-EGFP Yes – – None Yes
aYes, indicates that proteins could be optically resolved as colocalizing with
micropatterned EGF bound to EGFR; None, indicates no concentration of
label at EGF patterns was observed; and –, indicates not tested.Paxillin is recruited to and phosphorylated at
pattern-localized EGFR complexes
Paxillin, a multidomain adaptor protein, is known to partic-
ipate in integrin-mediated signaling as a part of focal adhe-
sions (30), as well as in other cell signaling contexts (31). In
this role, paxillin interacts with several actin cytoskeleton
regulating proteins, including vinculin and talin (32). We
previously found that paxillin is recruited to clustered IgE
receptor complexes, and it contributes to the regulation of
IgE receptor signaling (17). Prior studies showed paxillin
plays a role in the activation of Erk due to EGFR stimulation
in prostate cancer cells (12,13). We examined the distribu-
tion of paxillin-EGFP in NIH-3T3 (EGFR) cells under
conditions of EGFR clustering at the patterned features,
and we observed that paxillin-EGFP is visibly concentrated
at these features (Fig. 2 A, top panel). This concentration isBiophysical Journal 107(11) 2639–2651not observed in the absence of EGF-biotin (Fig. 2 A,
middle panel). Quantification of this colocalization using
Pearson’s cross-correlation analysis gives a value of ~0.25
FIGURE 2 Paxillin is recruited to EGF patterns in a ligand-dependent
manner. (A) NIH-3T3 (EGFR) cells transiently transfected with paxillin-
EGFP (green channel), were plated on micropatterned, covalently attached
A568-streptavidin (red channel) surfaces with EGF-biotin (top panel), or
without EGF-biotin (middle panel). The bottom panel shows the NIH-
3T3 (EGFR) cells transiently transfected with paxillin-EGFP and pretreated
with 10 mM Iressa overnight, before incubation on micropatterned EGF sur-
faces. Scale bar 20 mm. (B) Quantification by Pearson’s cross-correlation
coefficient compares the red and green channels; N> 20 cells for each sam-
ple in at least two independent experiments. Error bars represent mean 5
SE; **** indicates p% 0.0001, *** indicates p% 0.001. To see this figure
in color, go online.
Patterned EFG Stimulates a Signaling Complex 2643for paxillin-EGFP colocalization with A568-streptavidin
patches when EGF is present on the surface, a substantially
higher value than when EGF is absent from the surface
(r ~0.05, Fig. 2 B). Furthermore, this recruitment of paxil-
lin-EGFP is prevented by treatment of cells with Iressa,
demonstrating its dependence on tyrosine kinase activation
(Fig. 2 A, bottom panel, and Fig. 2 B).
Paxillin has multiple sites of phosphorylation that
mediate its binding to several different proteins (30). Paxil-
lin is phosphorylated at Tyr-31 and Tyr-118 by Src kinase
(33), and at Ser-83 (34) and Ser-126 (35) in an Erk-depen-
dent manner. We find that paxillin recruited to EGF patterns
is phosphorylated at Tyr-118 (and possibly Tyr-31), identi-
fied by labeling with anti-paxillin phospho-Tyr-118(Fig. S3 A). Paxillin recruited to clustered EGFR is also
phosphorylated at Ser-126 as detected by labeling with an
antibody specific for that phosphorylated residue. Quantifi-
cation of these results using Pearson’s cross-correlation
analysis shows statistically significant association of tyro-
sine phosphorylated paxillin (r ~0.41) and serine phosphor-
ylated paxillin (r ~0.28) at EGF features (Fig. S3 B). As
expected, tyrosine phosphorylation of recruited paxillin is
inhibited by pretreatment with 20 mM PP2, a well-known
Src kinase inhibitor. However, PP2 does not inhibit recruit-
ment of paxillin-EGFP or paxillin phosphorylated at serine
residues (Fig. S3 B). Together, these results indicate that
paxillin is recruited to clustered EGFR at the plasma
membrane in a ligand-dependent and EGFR kinase activ-
ity-dependent manner. Furthermore, recruited paxillin is
phosphorylated on tyrosine residues, likely by Src kinase,
but paxillin recruitment and serine phosphorylation do not
depend on Src activity.F-actin is recruited together with b1 integrin to
pattern-localized EGFR complexes
Our previous study showed that F-actin colocalizes with
IgE receptors (FcεRI) clustered in micron-scale patterns
(14). Similarly, we found that F-actin labeled with
Alexa488-phalloidin in NIH-3T3 (EGFR) cells localizes
at EGF features (Fig. 3 A). This concentration of F-actin
can be observed as soon as 10 min after plating the cells
and is maximal after 30 min at 37C (A. Singhai, unpub-
lished results). Inhibition of actin polymerization by
2 mM cytochalasin D during cell attachment substantially
reduces this localized accumulation (Fig. 3 B and
Fig. S4). We also found that Iressa inhibits stimulated
F-actin recruitment (Fig. S5), consistent with its inhibition
of tyrosine phosphorylation stimulated by the patterned
EGF-EGFR (Fig. S2) We evaluated whether ezrin or moe-
sin, which connect the actin cytoskeleton to the plasma
membrane under some conditions (36), become concen-
trated with EGFR at EGF features. We detected no signifi-
cant concentration of these proteins in three separate
experiments (Fig. 3, A and B).
Because paxillin and F-actin are often concentrated in
focal adhesions nucleated by integrins (37), we examined
whether integrins also localize to the EGFR signaling com-
plexes. Integrin a5b1 is an abundant integrin in NIH-3T3
cells (38), and we investigated the distribution of this integ-
rin in NIH-3T3 (EGFR) cells using an anti-b1 mAb. As
illustrated in Fig. 4 A, we find that this integrin localizes
to EGFR clusters at the patterned surfaces, but preferentially
at peripheral regions compared to the middle of adherent
cells. In contrast, phosphotyrosine detected by mAb 4G10
concentrates similarly at patterned EGF in the middle and
periphery of attached cells (Fig. 4 A). Interestingly, b1 clus-
tering at patterned features often appears more asymmetric
than that for EGFR or phosphotyrosine (see Fig. 4 A andBiophysical Journal 107(11) 2639–2651
FIGURE 3 F-actin coredistributes with EGFR complexes at the plasma
membrane. (A) NIH-3T3 (EGFR) cells were plated onto micropatterned
EGF surfaces (red channel) and immunolabeled with A488-phalloidin
(green channel, top panel), anti-moesin (middle panel), or anti-ezrin
(bottom panel). Scale bar 20 mm. (B) Quantification of colocalization by
Pearson’s cross-correlation coefficient compares the green channel with
the red channel; N > 20 cells per sample from two independent
experiments. Error bars represent mean 5 SE; **** indicates p %
0.0001, *** indicates p% 0.001. To see this figure in color, go online.
2644 Singhai et al.Fig. S1). We sought to quantify this difference in distribu-
tion with respect to the patterned features and to distinguish
different regions of the cell. We chose to analyze averaged
fluorescence distributions according to grouped features us-
ing a radial analysis approach that quantifies the fluores-
cence intensity as a function of the distance from the
center of the patterned feature (described in Materials and
Methods and Fig. S1). The results from this analysis for
both b1 integrin and phosphotyrosine label are shown in
Fig. 4 B. Consistent with the representative images inBiophysical Journal 107(11) 2639–2651Fig. 4 A, we find that b1-containing integrins are more high-
ly enriched at patterned EGF features that are at the cell pe-
riphery compared to those that are located under the middle
of these cells. In contrast, stimulated tyrosine phosphoryla-
tion is more uniformly localized at all patterned EGF fea-
tures in contact with the cells. These results suggest that
integrin concentration in regions where EGFR is clustered
depends on processes stimulated by EGF that are down-
stream of tyrosine phosphorylation.The Erk signaling pathway is recruited
to patterned EGF
EGFR activated by EGF initiates a signaling cascade lead-
ing to activation of Ras, MEK, and Erk (39,40). EGFR phos-
photyrosine residues are docking sites for binding of Grb2,
an adaptor protein that recruits and activates Son of seven-
less, which is a guanine nucleotide exchange factor that ac-
tivates Ras (41). To investigate whether proteins in the Erk
signaling pathway colocalize with clustered, activated
EGFR, EGFP-H-Ras was transiently expressed in NIH
3T3 (EGFR) cells, and these cells were plated on EGF-
patterned surfaces for 40 min at 37C. Confocal imaging
shows concentration of EGFP-H-Ras fluorescence with
patterned EGF in >95% of imaged cells (Fig. 5 A). We
observe similar recruitment of transiently transfected
EGFP-N-Ras to patterned EGF (A. Singhai, unpublished re-
sults). Recruitment of EGFP-H-Ras to patterned EGF is not
reduced by 20 mM PP2, consistent with Src kinase-indepen-
dent recruitment (A. Singhai, unpublished results).
Similar to results with EGFP-H-Ras, we also observed
colocalization of MEK and pErk with patterned EGF by
antibodies specific for these MAP kinase signaling compo-
nents (Fig. 5). Quantification of colocalization by Pearson’s
cross-correlation analysis shows limited but statistically sig-
nificant recruitment of these more downstream partners in
the Erk activation pathway in a ligand-dependent manner
(Fig. 5 B). In addition to their recruitment to clustered
EGFR, a noticeable fraction of the fluorescent label for
MEK and pErk becomes localized in the nucleus under
these conditions of cell activation (observed with
z-sectioning; A. Singhai, unpublished results). Together,
these results provide evidence for activation of the MAP
kinase signaling cascade in response to patterned EGF,
and the principal components of this cascade are detected
as part of a macromolecular signaling complex colocalizing
with EGFR at patterned EGF features.Recruitment of EGFR signaling partners to
patterned EGF depends on the actin cytoskeleton
We found that cytochalasin D does not inhibit tyrosine phos-
phorylation of EGFR clustered at EGF features, as detected
by anti-phosphotyrosine 1068 or anti-phosphotyrosine mAb
4G10 (Fig. S4), consistent with cytoskeletal independence
FIGURE 4 Integrin b1 exhibits preferential
localization at peripheral EGF-bound EGFR
signaling complexes. (A) NIH-3T3 (EGFR) cells
were plated onto micropatterned EGF surfaces
(red channel) and immunolabeled with an anti-b1
integrin primary antibody and A488-tagged sec-
ondary antibody (green channel) and subsequently
immunolabeled with an anti-phosphotyrosine
4G10 antibody and A633-tagged secondary anti-
body (blue channel). Panels display two represen-
tative cells. Scale bar 10 mm. (B) Radial
fluorescence analysis, as described in Materials
and Methods, was performed on b1 integrin and
phosphotyrosine labeling to provide a measure of
the average cell response for protein recruitment
at patterned EGF; N ¼ 25 cells from two indepen-
dent experiments. Error bars represent mean5 SE.
To see this figure in color, go online.
Patterned EFG Stimulates a Signaling Complex 2645of these early events. In contrast, cytochalasin D inhibits
recruitment of paxillin and pErk to patterned EGF, as sum-
marized by quantitative Pearson’s cross-correlation analysis
in Fig. 6 A. Consistent with these results, we observe that
cytochalasin D inhibits Erk activation by soluble EGF in
NIH-3T3 (EGFR) cells, as detected by Western blotting
(Fig. 6 B). Quantification of Erk phosphorylation stimulated
by soluble EGF in multiple experiments indicates ~50% in-
hibition with an optimal dose (2 mM) of cytochalasin D
(Fig. 6 C). These results suggest that F-actin stabilizes
EGFR signaling complexes formed by both soluble and sur-
face-immobilized EGF, thereby participating in Erk activa-
tion by EGFR in these cells.
We found that several other proteins are recruited to
EGFR signaling complexes in micron-scale patterns.
Dynamin 2 is a GTPase commonly implicated in the
endocytosis of receptors on cell surfaces by facilitating
fission of the forming endosomes from the plasma mem-
brane (42). We recently found that dynamin 2 plays a role
in organizing the actin cytoskeleton at the sites of IgE re-
ceptor endocytosis in response to cross-linking by soluble
antigens (A. Torres, D. Holowka, and B. Baird, unpub-
lished results). We find that dynamin 2-EGFP expressedin NIH-3T3 (EGFR) cells is recruited to patterned EGF
in >90% of the expressing cells (Fig. S6). This recruit-
ment is not inhibited by cytochalasin D, similar to obser-
vations with IgE receptors concentrated in micron-scale
patterns, suggesting that dynamin 2 is recruited in the
absence of F-actin localization (A. Singhai, unpublished
results).
PLCg1 is an enzyme that mediates hydrolysis of PI(4,5)
P2 to inositol 1,4,5-trisphosphate and diacylglycerol, and it
was previously shown to bind directly to activated EGFR
via its tandem SH2 domains (43). NIH-3T3 (EGFR) cells
transiently transfected with EGFP-tagged PLCg1 show
clear recruitment of this enzyme to patterned EGF
(Fig. S6). Because tyrosine phosphorylation of paxillin by
a Src kinase was previously shown to be stimulated by
EGF (12), we investigated whether the Src family kinase
Lyn tagged with mRFP colocalizes with EGFR signaling
complexes in micron-scale EGF patterns. As shown in
Fig. S6, we observe Lyn-mRFP concentrating with the
patterned features in ~60% of the expressing cells. This sug-
gests Src family kinases can be recruited to regions of acti-
vated EGFR complexes, providing a mechanism by which
these kinases can mediate phosphorylation of Tyr-118 inBiophysical Journal 107(11) 2639–2651
FIGURE 5 Proteins in the MAP kinase signaling cascade: Ras, MEK,
and pErk coredistribute with EGFR signaling complexes at the plasma
membrane. (A) NIH-3T3 (EGFR) cells transiently transfected with
EGFP-H-Ras (green channel, top panel), were plated on micropatterned
EGF surfaces. NIH-3T3 (EGFR) cells plated on micropatterned EGF sur-
faces, were fixed and subsequently immunolabeled with anti-MEK (green
channel, middle panel) or anti-phospho-Erk (green channel, bottom panel),
followed by A488-tagged secondary antibodies. Scale bar 20 mm. (B) Quan-
tification with Pearson’s cross-correlation coefficient is reported for the
green and red channels; N > 30 cells from three independent experiments.
Error bars represent mean5 SE; *** indicates p% 0.001, ** indicates p%
0.01. To see this figure in color, go online.
2646 Singhai et al.paxillin associated with the activated EGFR signaling com-
plexes (Fig. S2).Inhibition of PI(4,5)P2 synthesis interferes with
recruitment of F-actin, Erk, and dynamin 2 to
pattern-localized EGFR complexes
It is now well established that PI(4,5)P2 plays multiple roles
in regulating cell signaling (44). We recently showed that
two inhibitors of phosphoinositide synthesis, PAO and quer-
cetin, effectively inhibit multiple processes in IgE receptor
signaling in mast cells at concentrations that are selectiveBiophysical Journal 107(11) 2639–2651for inhibition of PI(4)P and PI(4,5)P2 synthesis (45). We
further found that under these conditions, these compounds
inhibit recruitment of F-actin to IgE receptor complexes
localized to micropatterned antigen (A. Singhai, unpub-
lished results). In NIH-3T3 (EGFR) cells, we find that pre-
treatment of cells with 2 mM PAO or 20 mM quercetin leads
to substantial reduction in F-actin recruitment to EGF pat-
terns, as detected by A488-phalloidin labeling (Fig. 7, A
and B). In addition, treatment with PAO or quercetin inhibits
recruitment of pErk at EGFR signaling complexes on
patterned EGF surfaces (Fig. 7 C). In other experiments
we found that these compounds prevent concentration of dy-
namin 2 with clustered EGFR bound to patterned EGF in
>95% of the imaged cells (A. Singhai, unpublished results),
suggesting that phosphoinositides play a role in this co-
localization that further leads to actin organization in these
regions.
To further evaluate the role of phosphoinositides in
assembly of EGFR signaling complexes, we coexpressed a
rapamycin-recruitable inositol 5-phosphatase, FKBP12-
5ptase, together with the plasma membrane-targeted rapa-
mycin binding domain, PM-CFP-FRB (24), in NIH 3T3
(EGFR) cells. We acutely recruited the inositol 5-phospha-
tase to the plasma membrane by the addition of 100 nM ra-
pamycin just before allowing these cells to settle on EGF
patterns. As shown in representative images in Fig. 8 A
and quantified by radial analysis in Fig. 8 B, we find that
inositol 5-phosphatase recruitment significantly reduces
the localization of F-actin at EGF patterns. These results
provide strong evidence that PI(4,5)P2, and possibly other
phosphoinositides, play a role in the stabilization of F-actin-
associated signaling complexes at patterned EGF sites.DISCUSSION
RTKs, including EGFR, are key regulators of cellular pro-
cesses such as proliferation, migration, and differentiation
(2). EGF binding to the extracellular domain of EGFR
causes dimerization leading to transphosphorylation of tyro-
sine residues in the C-terminal segments of these receptors.
Signal transduction propagates by recruitment of adaptor
proteins, such as Grb2 and Gab2, and enzymes, such as
PLCg1, to these phosphotyrosine residues. Recruited
adaptor proteins mediate activation of downstream signaling
cascades, including the MAP kinase cascade and PI3-kina-
se-dependent activation of Akt. The signaling pathways
leading to activation of these kinases have been established
(41,46,47), but detectable association of these signaling pro-
teins in EGFR complexes has not been previously demon-
strated. Micropatterned ligand arrays have been valuable
tools to study the interactions of cytoplasmic and mem-
brane-bound proteins with ligand-activated receptors at the
plasma membrane. We previously used such arrays to probe
the recruitment of signaling partners of activated IgE/FcεRI
complexes (16,17). In this study, we show for the first time,
FIGURE 6 Recruitment of pErk and paxillin
depend on F-actin polymerization. (A) NIH-3T3
(EGFR) cells transiently transfected with or
without paxillin-EGFP were pretreated with or
without 2 mM cytochalasin D before incubation
on the micropatterned EGF surfaces. Untrans-
fected NIH-3T3 (EGFR) cells were immu-
nolabeled with anti-phospho-Erk primary and
A488-tagged secondary antibodies. Quantification
of colocalization between paxillin and patterned
EGF or phosphorylated Erk and patterned EGF
were carried out using Pearson’s cross-correlation
coefficient analysis; N > 30 cells over two inde-
pendent experiments. (B) NIH-3T3 (EGFR) cells,
preincubated with or without 2 mM cytochalasin
D for 5 min, and then stimulated or not with
EGF (50 ng/ml, 4 min) were solubilized and pre-
pared for Western blotting. Proteins were fraction-
ated on sodium dodecyl sulfate gels and labeled
with anti-phospho-Tyr-1068, anti-EGFR, anti-
phospho-Erk, or anti-Erk antibodies. (C) Average
intensities of phospho-Erk bands are from Western
blots in three independent experiments. The inten-
sities were normalized for each individual experi-
ment (relative to pErk stimulated with EGF in
the absence of cytochalasin D). Error bars repre-
sent mean5 SE; *** indicates p% 0.001, * indi-
cates p % 0.05.
Patterned EFG Stimulates a Signaling Complex 2647to our knowledge, that EGF engagement of EFGR can cause
stable association of Erk signaling proteins in a signaling
complex.
In previous studies from other laboratories, covalently
immobilized EGF was shown to stimulate tyrosine phos-
phorylation in Chinese hamster ovary (CHO) cells overex-
pressing EGFR (19,48) and in breast cancer BT-20 cells
(18). These studies used EGF patterned on surfaces with
feature sizes of dimensions ~10–100 mm, and they found
that cells cultured on these surfaces show higher growth
rates compared to the cells plated on surfaces without
attached EGF. Our experiments use patterns of EGF-biotin
tightly bound to covalently attached A568-streptavidin in
features with subcellular dimensions of 1–4 mm, and we
observe for individual cells that EGFR accumulates at these
features and that tyrosine phosphorylation occurs in the
same patterned regions (Fig. 1). We further observe that
EGFR recruited to patterned EGF is directly tyrosine phos-
phorylated at Tyr-1068 (Fig. S2 A), consistent with previous
observations for EGFR stimulated with soluble EGF
(25,49). This strategy has permitted us to visualize interac-
tions with downstream signaling partners and F-actin under
conditions in which receptor endocytosis is prevented. In
initial experiments we found that EGFP-tagged EGFR
mediates endocytosis of rhodamine-EGF when this ligand
is simply adsorbed to the surface in a patterned array
(A. Singhai, unpublished results), demonstrating the impor-
tance of covalently attaching the ligand complex in micro-
patterned surfaces to visualize robust recruitment of
EGFR in spatially resolved clusters.In response to binding soluble EGF, cell surface EGFR di-
merizes in the process of activating its tyrosine kinase
domain leading to transphosphorylation (2). Our results
show that the local concentration of EGF at micropatterned
surfaces similarly causes tyrosine phosphorylation, a pro-
cess that is dependent on EGFR kinase activity and inhibited
by 10 mM Iressa. This treatment however does not inhibit
colocalization of EGFR with patterned EGF. This observa-
tion shows that EGFR kinase activity is not required for
EGFR binding to immobilized EGF, but that kinase activity
is required for activation leading to downstream signaling.
Using a resonance energy transfer fluorescence lifetime im-
aging-based method, Verveer et al. (8) detected stimulated
EGFR tyrosine phosphorylation distal to the region of
attachment to micron-sized EGF-conjugated beads on
MCF7 cells. A subsequent study provided evidence that
long-range propagation of EGFR activation depends on
high densities of receptor expression (50). In our stably
transfected NIH 3T3 cells, EGFR is moderately overex-
pressed (25). We observe that tyrosine phosphorylation is
largely confined to the patterned EGF features, as deter-
mined both by cross correlation and by radial analysis, but
we cannot exclude some component of more distal phos-
phorylation, such as the relatively low levels of off-pattern
labeling evident in Fig. 4 A.
Activated EGFR initiates a signaling cascade that leads to
activation of Ras, and our results show recruitment of
EGFP-H-Ras to clustered EGFR at the plasma membrane
(Fig. 5). Ras activates Raf kinase (51,52), which further ac-
tivates MEK to phosphorylate Erk in the MAP kinaseBiophysical Journal 107(11) 2639–2651
FIGURE 7 PI(4,5)P2 synthesis is implicated in the recruitment of F-actin
and phosphorylated Erk to EGFR signaling complexes. (A) NIH-3T3
(EGFR) cells were pretreated with 2 mM PAO (middle panel) or 20 mM
quercetin (bottom panel) or not treated (control; top panel) before plating
on micropatterned EGF surfaces. Cells were labeled with A488-phalloidin
(green channel) or anti-phospho-Erk antibody, followed by A488-tagged
secondary antibody (images not shown) after fixation. Scale bar 20 mm.
(B) Pearson’s cross-correlation analysis is shown for F-actin colocalization
with patterned EGF; N > 30 cells for at least two independent experiments.
(C) Similar analysis for colocalization of antibody-labeled phosphorylated
Erk with patterned EGF; N > 30 cells for at least two independent
experiments. Error bars represent mean 5 SE; **** indicates p %
0.0001, *** indicates p% 0.001. To see this figure in color, go online.
2648 Singhai et al.cascade (53). Postactivation, Erk and MEK are translocated
as a complex into the nucleus to initiate gene transcription,
which leads to cell division and proliferation among other
responses (54). Our experiments show that MEK and Erk
colocalize with activated EGFR clustered at the plasma
membrane by the micropatterned EGF surfaces (Fig. 5
and Table 1). Previously, these interactions have been diffi-
cult to detect, possibly due in part to limitations in optical
resolution or to EGFR endocytosis after activation by
EGF. Stabilization of EFGR signaling complexes in large
(micron-scale) clusters enhances detection of signaling part-Biophysical Journal 107(11) 2639–2651ners. Our results demonstrate that macromolecular com-
plexes of EGFR formed on the plasma membrane can
activate Erk colocalized with these complexes, along with
other members of this MAP kinase cascade, Ras and MEK.
Recent studies pointed to a role for paxillin in EGFR
signaling (12,13), and we find that paxillin-EGFP expressed
in NIH-3T3 cells colocalizes with the microclustered EGFR
at the plasma membrane in a process that depends on EGFR
kinase activity (Fig. 2). Paxillin is known be phosphorylated
on Tyr-31 and Try-118 by Src kinase, and on Ser-83 and Ser-
126 by Erk (30). In agreement, we observe tyrosine phos-
phorylation of paxillin recruited to EGFR signaling
complexes at the plasma membrane by labeling with anti-
phospho-paxillin antibodies (Fig. S2). Consistent with tyro-
sine phosphorylation of paxillin by Src (33), we observe
recruitment of Lyn, a Src family kinase, to clustered EGFR
at the plasma membrane (Fig. S3). Treatment with the Src
family kinase inhibitor PP2 inhibits tyrosine phosphoryla-
tion of paxillin colocalized with these clusters, and this
treatment causes a small increase in the recruitment of pax-
illin-EGFP and phospho-Ser-paxillin as quantified by Pear-
son’s cross-correlation analysis (Fig. S2). This suggests
enhanced association of paxillin with clustered EGFR in
the absence of Src kinase activity. Under these conditions,
the activity of Src kinase is not critical for the activation of
Erk, as observed in experiments with patterned EGF, as
well as with soluble EGF (K. Bryant, unpublished results).
In contrast, others have shown reduced Erk activation in
the presence of PP2 in prostate cancer cells (12). This
distinction is possibly due to differences in cell types and dif-
ferential contributions of other signaling pathways, such as
the formation of focal adhesions, which may be more impor-
tant for activation of Erk kinase in prostate cancer cells.
Our previous experiments that characterized IgE-FcεRI
signaling using micropatterned ligands showed that F-actin
is recruited to the clustered FcεRI complexes (16,17). We
further observed that the Src family kinase Lyn, chiefly
responsible for the phosphorylation of FcεRI, is visibly re-
cruited to the clustered FcεRI. In these experiments,
micron-scale accumulation of Lyn with FcεRI at patterned
ligands was prevented by cytochalasin D, even though tyro-
sine phosphorylation of FcεRI was enhanced, indicating the
presence of catalytically active Lyn in subdetectable
amounts (16). Based on these previous experiments, we hy-
pothesized that actin polymerization stabilizes EGFR
signaling complexes at the plasma membrane, even though
a high level of stabilization is not essential for signal initia-
tion. Our present results show recruitment of F-actin to mi-
croclustered EGFR, whereas the actin-binding proteins
ezrin and moesin do not visibly colocalize with the EGF fea-
tures (Fig. 3). Consistent with our observations with FcεRI,
we find that cytochalasin D prevents detectable recruitment
of more downstream partners such as paxillin, H-Ras, and
Erk to the EGFR signaling complexes at the plasma mem-
brane (Fig. 6 and A. Singhai, unpublished results). In
FIGURE 8 Rapamycin-dependent recruitment
of an inositol 5-phosphatase supports a role for
phosphoinositides in F-actin localization to
EGFR signaling complexes at patterned EGF fea-
tures. (A) NIH-3T3 (EGFR) cells transiently trans-
fected with PM2-CFP-FRB (cyan channel) and
FKBP12-5ptase are briefly treated with 100 nM ra-
pamycin (Rapa) for 5 min at 37C before plating on
EGF patterns (red channel). The cells are fixed and
subsequently labeled for F-actin using A647-phal-
loidin (blue channel). Representative images are
shown for a cell not treated with Rapa (top panel)
and a cell treated with 100 nM Rapa (bottom
panel). Scale bar: 10 mm. (B) Radial fluorescence
analysis for F-actin recruitment at patterned EGF
was performed for both the untreated and Rapa
treated cases; N ¼ 22 from two independent exper-
iments. Error bars represent mean5 SE; *** indi-
cates p% 0.001, **indicates p% 0.01. To see this
figure in color, go online.
Patterned EFG Stimulates a Signaling Complex 2649contrast, pretreatment with cytochalasin D does not visibly
inhibit recruitment or tyrosine phosphorylation of EGFR or
the recruitment of dynamin 2 in an EGF-dependent manner.
Although a previous study showed no effect of cytochalasin
D on EGF-dependent activation of Erk in Rat 1a fibroblasts
(55), we find that cytochalasin D causes ~50% inhibition of
Erk activation in NIH-3T3 (EGFR) cells stimulated with
soluble EGF (Fig. 6). These results suggest some cell
type-specific differences in the role of F-actin in stabilizing
macromolecular signaling complexes formed with clustered
EGFR at the plasma membrane.
Paxillin, F-actin, and integrins are known to participate in
focal adhesion complexes. These macromolecular structures
are formed at sites of cell interactions with the extracellular
matrix (37) and have the capacity to activate Erk through in-
tegrin-fibronectin-mediated signaling (56).Moreover, studies
have shown that integrins can associatewithEGFR, and integ-
rin-dependent cell adhesion contributes to EGFRactivation in
an F-actin-dependent manner (57,58). We find that b1-con-
taining integrins become localized to patterned-recruited
EGFR signaling complexes, but exhibit higher concentrations
at the more peripheral EGF patterned features in contact with
individual NIH-3T3 (EGFR) cells. This suggests recruitment
that correlates with a more dynamic engagement of the cells
with these patterns, possibly due to filopodia extension medi-
ating initial attachments to these peripheral sites. F-actin
recruitment sometimes appears more concentrated at these
peripheral sites, especially in cases of cellular extensions,suggesting possible focal adhesion complex formation. Pref-
erential recruitment of b1 integrin to peripheral EGF features
is consistently more pronounced compared to F-actin recruit-
ment, suggesting that F-actin association with EGF-clustered
EGFR does not depend on integrin recruitment or filopodia
extension. Furthermore, downstream signaling proteins that
stably associate with EGFR at EGF features in an F-actin-
dependentmanner, including paxillin and pErk, do not appear
to associate preferentially with more peripheral features.
Future studies will assess the extent to which focal adhesion
formation contributes to the more downstream signaling con-
sequences of EGFR activation by patterned EGF.
After EGFR is activated by binding to soluble EGF, it is
normally endocytosed (7). With micropatterned EGF sur-
faces, we find that clathrin is visibly concentrated at EGF
features in ~35% of the cells (A. Singhai, unpublished
results). By comparison, we observe that dynamin 2, a
GTPase implicated for its role in both clathrin-dependent
(59) and clathrin-independent endocytosis (60), colocalizes
with patterned EGF in >90% of cells. The actin cytoskel-
eton has been implicated in endocytosis of EGFR (61),
and its accumulation at EGFR complexes may contribute
to this process with soluble EGF, in addition to its role in
stabilizing associations with downstream signaling partners
described previously. Our results, taken together, suggest
that some of the proteins recruited to clustered EGFR may
be a part of the EGFR endocytic pathway, even though
endocytosis of EGFR is prevented by the attachment ofBiophysical Journal 107(11) 2639–2651
2650 Singhai et al.EGF to the silicon substrate. Furthermore, our results sup-
port previous evidence that endocytosis of EGFR is not
necessary for activation of the MAP kinase cascade (11).
Phosphoinositides are known to play important roles in
cell signaling in all cell types, as well as in receptor endocy-
tosis (44). Our results in Fig. 7 indicate that recruitment of
F-actin and pErk to patterned EGF are inhibited by pretreat-
ment with PAO or quercetin at concentrations that selectively
inhibit phosphoinositide synthesis (45). Furthermore, acute
recruitment of an inositol 5-phosphatase to the plasma mem-
brane by rapamycin also inhibits recruitment of F-actin to
EGF patterns, and this provides even stronger evidence that
phosphoinositides play an important role in the F-actin stabi-
lization of signaling complexes in this situation.
Consistent with these results, PI(4,5)P2 has been impli-
cated in the organization of the actin cytoskeleton (44,62). In-
hibition of pErk recruitment to patterned EGF by inhibitors
of phosphoinositide synthesis may be a consequence of inhi-
bition of F-actin recruitment, as cytochalasin D also inhibits
pErk recruitment (Fig. 6). Our results further show that dyna-
min 2, which binds PI(4,5)P2 via its PH domain (46,47), is
prevented from colocalization with clustered EGFR
signaling complexes by PAO or quercetin, even though dyna-
min 2 recruitment is not inhibited by cytochalasin D (A.
Torres and A. Singhai, unpublished results). This suggests
that dynamin 2 recruitment to the patterned EGFR signaling
complexes depends on association with PI(4,5)P2 in a step
that is upstreamof F-actin recruitment. Participation of dyna-
min 2 in the organization of F-actin with clustered EGFR
signaling complexes is a subject of continuing interest.
In conclusion, we have shown that micropatterned
EGF surfaces with quantitative image analysis schemes pro-
vide new, to our knowledge, insights into the structural orga-
nization of EGFR signaling complexes. This approach
complements traditional biochemical methods such as
immunoprecipitation of solubilized EGFR to detect interac-
tions of signaling partners. As summarized in Table 1, our
experiments show direct evidence for the formation of
macromolecular EGFR signaling complexes that include
PLCg1, H-Ras, MEK, and pErk, in addition to paxillin,
F-actin, and dynamin 2. Our results provide evidence that
phosphoinositide synthesis and the actin cytoskeleton
participate in the stabilization of these EGFR signaling
complexes, in addition to possible roles for these in EGFR
endocytosis. Our results reveal how stabilization of EGFR
signaling complexes by patterned EGF ligand contributes
to robust downstream signaling.SUPPORTING MATERIAL
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